A Phase 4 Trial to Describe the Immunogenicity, Safety, and Tolerability of MenB ‐ fHbp in Participants > 10 Years of Age With Asplenia or Complement Deficiency
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!